George P. Sillup, Ph.D.
Associate Professor of Pharmaceutical and Healthcare Marketing
Office: Mandeville 246
- Ph.D., The Fielding Institute
- M.S., Drexel University
- B.A., Wilkes University
Dr. Sillup worked in the healthcare industry from 1973-2004 at various positions from entry-level salesman to CEO. His responsibilities included conducting research, selling products and introducing several new medical/pharmaceutical businesses to international markets.
Additionally, he lead research teams that developed pharmaeconomic studies to support pricing and sales of several products. Dr. Sillup attained favorable reimbursement coverage determinations and coding for pharmaceuticals, medical devices and drug-device combination products from the United States and international governments.
Dr. Sillup has served as the scientific advisor for the Daemion Counseling Center since 1996. Daemion Counseling helps provide healthcare to those who cannot afford coverage.
As the new chairman of the Pharmaceutical & Healthcare Marketing department, Dr. Sillup pioneered the department's name change to include ‘healthcare' as part of our majors' curriculum. This evolution will better prepare our majors for the growing number of opportunities in the biotech, medical device and healthcare sectors.
In 2010, Dr. Sillup was elected Vice President of the Northeast Business & Economics Association (NBEA) and was instrumental in bringing the 38th Annual NBEA Conference to Philadelphia in November, 2011.
PMK 341 - Pharmaceutical Channels & Pricing
Pharm Exec's Seventh Annual Media Audit with Dr. Stephen J. Porth, '80, Associate Dean, Haub School of Business
Pharmaceutical Executive Magazine, March 2011
Pharm Exec's Sixth Annual Media Audit with Dr. Stephen J. Porth, '80, Associate Dean, Haub School of Business
Pharmaceutical Executive Magazine, March 2010
InforMeD Program (2010) with Dr. Edward R. Balotsky, Assistant Professor of Management, Haub School of Business
Presentation delivered to neighbors of the Saint Joseph's community documenting the changes in Medicare for Medicare-eligible residents
- Ethics in business and management, focusing on the pharmaceutical & healthcare industry
- Decision modeling to evaluate R&D efficiency
- Portfolio optimization
Mentioned in SJU News
Haub School Review, Fall 2012